Skip to Main Content

Author Details

Larissa B Thackray
Washington University School of Medicine
1996
60
35
PMIDPaper TitleJournal TitlePublished Year
36265510Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.Nat Med2023
37562033An Antiviral Role for TRIM14 in Ebola Virus Infection.J Infect Dis2023
37703353Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.Sci Transl Med2023
34846168Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.Sci Transl Med2022
35584653mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.Med2022
35452622Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.Cell2022
36238717Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains.bioRxiv2022
35891553Kathryn V. Holmes: A Career of Contributions to the Coronavirus Field.Viruses2022
36263060Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant.bioRxiv2022
34849936Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.Inflamm Bowel Dis2022
35169795Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice.bioRxiv2022
34373857Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.bioRxiv2021
33636133Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis.Cell2021
33501445Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.bioRxiv2021
34981044The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters.Res Sq2021
34462745Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.bioRxiv2021
34428107Helminth-virus interactions: determinants of coinfection outcomes.Gut Microbes2021
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
34051754Hypergraph models of biological networks to identify genes critical to pathogenic viral response.BMC Bioinformatics2021
32511409Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals.bioRxiv2020
31996462Immune correlates of tuberculosis disease and risk translate across species.Sci Transl Med2020
33208938LDLRAD3 is a receptor for Venezuelan equine encephalitis virus.Nature2020
32747832Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics.Nat Biomed Eng2020
32591393A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.J Immunol2020
32695842Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection.Mol Ther Methods Clin Dev2020
32668443Potently neutralizing and protective human antibodies against SARS-CoV-2.Nature2020
32668198The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.Cell2020
32553273A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.Cell2020
32511414Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.bioRxiv2020
31226645A long-distance relationship: the commensal gut microbiota and systemic viruses.Curr Opin Virol2019
31697791Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins.PLoS Pathog2019
29590614Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections.Cell Rep2018
28091625MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling.Analyst2017
24899198ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle.J Virol2014
25031348Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.J Virol2014
23300459IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling.PLoS Pathog2013
23860770A mouse model for human norovirus.mBio2013
22258242Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo.J Virol2012
22973039Essential cell-autonomous role for interferon (IFN) regulatory factor 1 in IFN-γ-mediated inhibition of norovirus replication in macrophages.J Virol2012
22951832Adaptive immunity restricts replication of novel murine astroviruses.J Virol2012
23035219Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.J Virol2012
23063120Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome.Cell2012
22520467Nondegradative role of Atg5-Atg12/ Atg16L1 autophagy protein complex in antiviral activity of interferon gamma.Cell Host Microbe2012
21880757The interferon-inducible gene viperin restricts West Nile virus pathogenesis.J Virol2011
18199653Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.J Virol2008
18495770A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo.J Virol2008
18024676Detection of murine norovirus 1 by using plaque assay, transfection assay, and real-time reverse transcription-PCR before and after heat exposure.Appl Environ Microbiol2008
17700057Coronavirus replication does not require the autophagy gene ATG5.Autophagy2007
17581883Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA.Proc Natl Acad Sci U S A2007
17652401Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence.J Virol2007
  • 1 - 50 of 60

Recommended Authors

James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 5
Aminu S Jahun
University of Cambridge, Addenbrooke's Hospital Level 5
Career Start Year 2017
Number of shared co-authors 1
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2016
Number of shared co-authors 14
Anshu P Gounder
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2012
Number of shared co-authors 0
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 4
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 5
James Zengel
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 2
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 24
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 4
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 3
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 11
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 4
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 9
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 19
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 8
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 2
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 5
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 3
James D Chappell
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 11
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 7
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 6
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 18
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 27
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 1
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 14
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 5
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Career Start Year 1989
Number of shared co-authors 20
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 11

Collaborators

Michael S Diamond
Washington University School of Medicine
Co-authored papers 35
Rita E Chen
Co-authored papers 7
Robert H Carnahan
Vanderbilt University Medical Center
Co-authored papers 6
James E Crowe
Vanderbilt University Medical Center
Co-authored papers 6
Ralph S Baric
University of North Carolina
Co-authored papers 6
Laura A VanBlargan
Washington University School of Medicine
Co-authored papers 5
Guillaume B E Stewart-Jones
Co-authored papers 5
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 5
Pavlo Gilchuk
Vanderbilt University Medical Center
Co-authored papers 5
Scott A Handley
Washington University School of Medicine
Co-authored papers 4
Thaddeus S Stappenbeck
Co-authored papers 4
Dan H Barouch
Co-authored papers 3
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers 3
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers 3
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 2
Stephen D Schmidt
Co-authored papers 2
Katrina M Waters
Pacific Northwest National Laboratory
Co-authored papers 2
Vineet D Menachery
University of Texas Medical Branch
Co-authored papers 2
Mehul S Suthar
Co-authored papers 2
Gwo-Yu Chuang
Co-authored papers 2
Sijy O'Dell
Co-authored papers 2
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 2
Siyuan Ding
Washington University School of Medicine
Co-authored papers 2
Michael J Holtzman
Co-authored papers 2
Nicole A Doria-Rose
Co-authored papers 2
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers 2
Ramnik J Xavier
Broad Institute of MIT and Harvard
Co-authored papers 2
Kelly G Stratton
Pacific Northwest National Laboratory
Co-authored papers 2
Adrianus C M Boon
Co-authored papers 2
Matthew J Gorman
Co-authored papers 2
Release 1.2